At the 2025 International Kidney Cancer Symposium, Dr. Michael Staehler, of the University of Munich, highlighted the ...

A local family is turning to the community for support as longtime emergency medical technician William Miller begins treatment for kidney cancer. Kelsey Miller told Jersey Shore Online that her ...

One team will be joyfully exuberant, celebrating a victory wrought from the most nerve-wracking tension. That ecstasy will ...

DENVER -- Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had ...

Calayah had her entire family by her side for the celebration. Aunts, uncles and cousins came in from Florida and Michigan to ...

DENVER -- Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...

KWTX@4's Justin Earley & Lauren Westbrook sit down with Dr. Nilesh Goswami, a cardiologist with Baylor Scott and White ...

Arginase 1 (Arg1) is a key mediator of immune suppression, and its overexpression has been reported in multiple cancers, including renal cell carcinoma, pancreatic cancer, and head and neck cancer.